Leukemia cell lines

Leukemia cell lines are immortalized populations of cells derived from patients with various types of leukemia, such as acute myeloid leukemia (AML) or chronic myeloid leukemia (CML) (Source: NIH). These lines, including well-known examples like K562, HL-60, and Jurkat, serve as essential in vitro models for studying the biology of blood cancers (Source: Cellosaurus). They are primarily used as platforms for high-throughput drug screening and for the validation of specific molecular targets (Source: PubMed). It is important to clarify that leukemia cell lines are not therapeutic targets themselves; rather, they are biological systems used to identify and test drugs against targets like BCR-ABL or FLT3 (Source: Nature Reviews Cancer). While they facilitate the discovery of new treatments, they possess limitations such as genetic instability and the absence of a physiological bone marrow microenvironment (Source: StatPearls). Researchers use these lines to identify biomarkers and mechanisms of drug resistance before moving to clinical trials (Source: Wikipedia).

Other names

Leukemic cell linesHematopoietic cancer cell linesIn vitro leukemia modelsImmortalized leukemia cells

Not applicable; leukemia cell lines are biological model systems used for research rather than molecular targets for drug binding.